Statistics for Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
Total visits
| views | |
|---|---|
| Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period | 0 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:8bdbeac9-a2c0-4d4f-a5ba-7cd68e40b639 | 33 |
| java.util.UUID:171a6662-1f0c-49cd-8274-bb9d0ca22813 | 22 |
| java.util.UUID:a2da4ebd-4c1b-416e-b313-40fd6a3b5723 | 8 |
| Ward2024Burosumab-CCBY.pdf | 3 |